科拓生物：公司不对第三方产品的效果或价格作评价，品牌间因定位与配方差异不具可比性

Core Viewpoint - The company, Keta Bio (300858), emphasizes the unique formulation and functional claims of its probiotic product, ProSci-246, which focuses on gut microbiota management and weight management support [1] Group 1 - The company responded to investor inquiries on August 25 regarding its probiotic product, highlighting its specific focus on gut microbiota management [1] - Keta Bio clarifies that the formulations and functional claims of its products differ from those of other companies, indicating a lack of comparability due to differences in positioning and formulation [1] - The company does not evaluate the effectiveness or pricing of third-party products, reinforcing its distinct market position [1]